A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa) (NCT06749457)
A Phase I/IIa Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacokinetics of AZD7760 in Healthy Participants and in Patients With End-stage Kidney Disease Receiving Hemodialysis Through a Central Venous Catheter
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of AZD7760 when given as an intravenous infusion to healthy participants (Phase I) or participants with end-stage kidney disease receiving hemodialysis through a central venous catheter (Phase IIa).
Who can join: Review the eligibility criteria below.
Location: Research Site — Huntsville, Alabama
Age range: 18 Years to 55 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (44 Sites)
Showing the first 25 of 44 sites.
- Research Site — Huntsville, Alabama
- Research Site — Chula Vista, California
- Research Site — Chula Vista, California
- Research Site — Glendale, California
- Research Site — Granada Hills, California
- Research Site — Los Angeles, California
- Research Site — Northridge, California
- Research Site — Northridge, California
- Research Site — Oxnard, California
- Research Site — Riverside, California
- Research Site — San Dimas, California
- Research Site — Tarzana, California
- Research Site — Valencia, California
- Research Site — Victorville, California
- Research Site — Englewood, Colorado
- Research Site — Bradenton, Florida
- Research Site — Coral Springs, Florida
- Research Site — Hollywood, Florida
- Research Site — Orlando, Florida
- Research Site — Tampa, Florida
- Research Site — Lawrenceville, Georgia
- Research Site — Chicago, Illinois
- Research Site — Chicago, Illinois
- Research Site — Iowa City, Iowa
- Research Site — Lexington, Kentucky
📞 Contact the Study Coordinator
Phone: (877) 240-9479
Email: information.center@astrazeneca.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Staphylococcus Aureus
- Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant — Baltimore, Maryland
- Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome — Baltimore, Maryland
Explore by condition: All Staphylococcus Aureus clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.